Qube Research & Technologies (QRT) Portfolio holdings
AUM
$72B
1-Year Return
7.86%
This Quarter Return
+5.95%
1 Year Return
+7.86%
3 Year Return
+23.62%
5 Year Return
+38.38%
10 Year Return
–
AUM
$16.6B
AUM Growth
+$951M
(+6.1%)
Cap. Flow
+$96.2M
Cap. Flow
% of AUM
0.58%
Top 10 Holdings %
Top 10 Hldgs %
7.86%
Holding
3,168
New
755
Increased
828
Reduced
689
Closed
831
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$104M |
| 2 |
Goldman Sachs
GS
|
+$103M |
| 3 |
Steel Dynamics
STLD
|
+$101M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$95.5M |
| 5 |
PepsiCo
PEP
|
+$95.1M |
Top Sells
| 1 |
Chevron
CVX
|
+$145M |
| 2 |
Exxon Mobil
XOM
|
+$141M |
| 3 |
Microsoft
MSFT
|
+$140M |
| 4 |
Coca-Cola
KO
|
+$140M |
| 5 |
Broadcom
AVGO
|
+$129M |
Sector Composition
| 1 | Technology | 19.03% |
| 2 | Industrials | 13.07% |
| 3 | Consumer Discretionary | 12.98% |
| 4 | Healthcare | 12.98% |
| 5 | Financials | 12.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
iShares Russell 2000 Value ETF
IWN
$11.9B
| $167K | ﹤0.01% |
+1,205
| New | +$167K |
|
1802
Fennec Pharmaceuticals
FENC
$244M
| $166K | ﹤0.01% |
+17,272
| New | +$166K |
|
1803
Dimensional US Core Equity 2 ETF
DFAC
$37.7B
| $165K | ﹤0.01% |
6,816
-1,985
| -23% | -$48.2K |
|
1804
SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$14.4B
| $165K | ﹤0.01% |
3,884
+342
| +10% | +$14.5K |
|
1805
Invesco S&P 500 Revenue ETF
RWL
$6.55B
| $165K | ﹤0.01% |
2,226
+926
| +71% | +$68.5K |
|
1806
Organogenesis Holdings
ORGO
$625M
| $165K | ﹤0.01% |
61,162
-254,056
| -81% | -$683K |
|
1807
ADMA Biologics
ADMA
$3.84B
| $163K | ﹤0.01% |
42,073
-250,890
| -86% | -$973K |
|
|
AGS
1808
DELISTED
PlayAGS
AGS
| $163K | ﹤0.01% |
31,916
+7,437
| +30% | +$37.9K |
|
1809
First Trust Materials AlphaDEX Fund
FXZ
$218M
| $162K | ﹤0.01% |
2,677
-8,557
| -76% | -$518K |
|
1810
Invesco Senior Income Trust
VVR
$535M
| $162K | ﹤0.01% |
42,285
| – | – |
|
1811
Pacer Global Cash Cows Dividend ETF
GCOW
$2.46B
| $162K | ﹤0.01% |
5,100
+3,004
| +143% | +$95.3K |
|
1812
Lineage Cell Therapeutics
LCTX
$306M
| $161K | ﹤0.01% |
137,568
+34,246
| +33% | +$40.1K |
|
|
RPT
1813
Rithm Property Trust Inc.
RPT
$124M
| $160K | ﹤0.01% |
22,022
+7,615
| +53% | +$55.2K |
|
|
JMIA
1814
Jumia Technologies
JMIA
$1.21B
| $159K | ﹤0.01% |
+49,568
| New | +$159K |
|
1815
Diana Shipping
DSX
$225M
| $159K | ﹤0.01% |
51,141
-76,333
| -60% | -$237K |
|
1816
Repare Therapeutics
RPTX
$75.6M
| $157K | ﹤0.01% |
10,664
-1,569
| -13% | -$23.1K |
|
1817
Fidelity MSCI Financials Index ETF
FNCL
$2.37B
| $155K | ﹤0.01% |
3,240
+2,742
| +551% | +$131K |
|
1818
Huadi International Group
HUDI
$22.1M
| $155K | ﹤0.01% |
+30,574
| New | +$155K |
|
1819
Matrix Service
MTRX
$353M
| $155K | ﹤0.01% |
24,879
+1,122
| +5% | +$6.98K |
|
1820
Kezar Life Sciences
KZR
$28.9M
| $155K | ﹤0.01% |
+2,195
| New | +$155K |
|
1821
Riverview Bancorp
RVSB
$102M
| $154K | ﹤0.01% |
20,040
+3,486
| +21% | +$26.8K |
|
1822
Beyond Air
XAIR
$12.7M
| $154K | ﹤0.01% |
1,185
-105
| -8% | -$13.6K |
|
1823
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$223M
| $154K | ﹤0.01% |
+3,912
| New | +$154K |
|
1824
InfuSystem Holdings
INFU
$204M
| $153K | ﹤0.01% |
17,607
+3,649
| +26% | +$31.7K |
|
1825
Assertio
ASRT
$78.3M
| $153K | ﹤0.01% |
+35,491
| New | +$153K |
|